DMKC Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,662
Closed -$509K 76
2025
Q2
$509K Buy
2,662
+1,327
+99% +$247K 0.27% 65
2025
Q1
$280K Hold
1,335
0.25% 51
2024
Q4
$237K Buy
+1,335
New +$245K 0.22% 53

Other funds holding ABBV

DMKC Advisory Services's ABBV Position: Q3 2025 in Review

DMKC Advisory Services sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 2,662 shares — an estimated $509K sold.

DMKC Advisory Services first reported a position in ABBV in Q4 2024 and held it in 3 quarters. The position peaked at $509K in Q2 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • DMKC Advisory Services reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • DMKC Advisory Services sold 2,662 AbbVie shares in Q3 2025, an estimated $509K.
  • DMKC Advisory Services first reported a position in AbbVie in Q4 2024 and held it in 3 quarters.
  • DMKC Advisory Services's AbbVie position peaked at $509K in Q2 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on DMKC Advisory Services's 13F filing for Q3 2025, filed 21 Oct 2025.